News

CENTOGENE announced today the opening of its first U.S. based rare disease laboratory in Cambridge, Massachusetts. The new facility, opening on August…

CENTOGENE, driving the diagnostic workflows and individualized therapeutic decisions not only in rare diseases but also in oncological setups is proud…

CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and…

CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and…

Collaboration Builds on Genetic Identification of Patients with Sjögren-Larsson Syndrome (SLS) in a Worldwide Cohort Enabling SLS Patients to Benefit…

Dr. Arndt Rolfs talks at ECRD about speeding up the rare disease knowledge and information eco-system based on proteomic screening tools

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials

CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients,…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

CENTOGENE highlights solutions for early diagnosis of rare hereditary disorders at the 2nd Annual Recent Advances in Rare Disease Conference.

CENTOGE…